{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:51:13Z","timestamp":1791093073952,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T00:00:00Z","timestamp":1397174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094733","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T21:09:19Z","timestamp":1397250559000},"page":"e94733","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis"],"prefix":"10.1371","volume":"9","author":[{"given":"Francisco J.","family":"Carrillo-Salinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Mecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Feli\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Collado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cantarero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Bellido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Guaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.expneurol.2009.10.009","article-title":"Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models","volume":"225","author":"H Lassmann","year":"2010","journal-title":"Exp Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"A Compston","year":"2008","journal-title":"Lancet"},{"key":"ref3","volume":"15","unstructured":"Miller SD, Karpus WJ and Davidson TS (2010) Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol Chapter <volume>15<\/volume> : Unit 15 11."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-5728(92)90152-B","article-title":"Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system","volume":"37","author":"Y Matsumoto","year":"1992","journal-title":"J Neuroimmunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm1177","article-title":"Experimental autoimmune encephalomyelitis repressed by microglial paralysis","volume":"11","author":"FL Heppner","year":"2005","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.20913","article-title":"How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis","volume":"60","author":"L Steinman","year":"2006","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2011.09.002","article-title":"Phytocannabinoids as novel therapeutic agents in CNS disorders","volume":"133","author":"AJ Hill","year":"2012","journal-title":"Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1091256","article-title":"Neuroscience. Stout guards of the central nervous system","volume":"302","author":"R Mechoulam","year":"2003","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"JC Ashton","year":"2007","journal-title":"Curr Neuropharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","article-title":"Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease","volume":"215","author":"SE O'Sullivan","year":"2010","journal-title":"Immunobiology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.05.025","article-title":"Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens","volume":"226","author":"K Venken","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Y Komiyama","year":"2006","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"H Park","year":"2005","journal-title":"Nat Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"M Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nn.3505","article-title":"Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells","volume":"16","author":"Z Kang","year":"2013","journal-title":"Nat Neurosci"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Guillot A, Hamdaoui N, Bizy A, Zoltani K, Souktani R, <etal>et al<\/etal>.. (2013) Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver. Hepatology.","DOI":"10.1002\/hep.26598"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"H Kebir","year":"2007","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"J Huppert","year":"2010","journal-title":"FASEB J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid, cannabigerol, in experimental inflammtory bowell","volume":"85","author":"F Borrelli","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11481-012-9399-3","article-title":"A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis","volume":"7","author":"AG Granja","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2013.03.002","article-title":"Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination","volume":"333","author":"A Rostami","year":"2013","journal-title":"J Neurol Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4049\/jimmunol.156.5.1788","article-title":"CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response","volume":"156","author":"LG Radvanyi","year":"1996","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2009.12.034","article-title":"Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice","volume":"222","author":"D Gomez-Nicola","year":"2010","journal-title":"Exp Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","article-title":"Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord","volume":"29","author":"KA Kigerl","year":"2009","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.172.4.1025","article-title":"Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages","volume":"172","author":"I Huitinga","year":"1990","journal-title":"J Exp Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO;2-Y","article-title":"Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology","volume":"29","author":"A Bitsch","year":"2000","journal-title":"Glia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(02)00102-3","article-title":"The role of nitric oxide in multiple sclerosis","volume":"1","author":"KJ Smith","year":"2002","journal-title":"Lancet Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood-2003-11-4025","article-title":"High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay","volume":"103","author":"MP Crawford","year":"2004","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"JM Fletcher","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.179.6.4135","article-title":"IL-17 enhances chemokine gene expression through mRNA stabilization","volume":"179","author":"J Hartupee","year":"2007","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4049\/jimmunol.0902423","article-title":"IL-17 regulates CXCL1 mRNA stability via an AUUUA\/tristetraprolin-independent sequence","volume":"184","author":"S Datta","year":"2010","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation","volume":"181","author":"NG Innamorato","year":"2008","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"324256","DOI":"10.1155\/2012\/324256","article-title":"Therapeutic approach to neurodegenerative diseases by medical gases: focusing on redox signaling and related antioxidant enzymes","volume":"2012","author":"K Fujita","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410370404","article-title":"The adhesion molecule and cytokine profile of multiple sclerosis lesions","volume":"37","author":"B Cannella","year":"1995","journal-title":"Ann Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-5728(03)00262-5","article-title":"Increased ICAM-1 and VCAM-1 expression in the brains of autoimmune mice","volume":"142","author":"A Zameer","year":"2003","journal-title":"J Neuroimmunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2010.08.011","article-title":"Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE","volume":"229","author":"J Bennett","year":"2010","journal-title":"J Neuroimmunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1074\/jbc.M707960200","article-title":"The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis","volume":"283","author":"J Palazuelos","year":"2008","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ana.10206","article-title":"Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis","volume":"51","author":"DL Feinstein","year":"2002","journal-title":"Ann Neurol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T02:05:14Z","timestamp":1689127514000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094733"}},"subtitle":[],"editor":[{"given":"Guadalupe","family":"Mengod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,11]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094733","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,11]]}}}